Source: https://regulations.justia.com/regulations/fedreg/agencies/national-aeronautics-and-space-administration/2005
Timestamp: 2020-01-19 21:59:05
Document Index: 320493010

Matched Legal Cases: ['Application No. 98915320', 'Application No. 10', 'Application No. 2286349', 'Application No. 132264', 'Application No. 999265', 'Application No. 98915320']

Document Number: E5-7736
https://regulations.justia.com/regulations/fedreg/2005/12/23/E5-7736.html
Document Number: E5-7735
https://regulations.justia.com/regulations/fedreg/2005/12/23/E5-7735.html
Document Number: E5-7734
https://regulations.justia.com/regulations/fedreg/2005/12/23/E5-7734.html
Document Number: E5-7733
https://regulations.justia.com/regulations/fedreg/2005/12/23/E5-7733.html
Document Number: E5-7732
https://regulations.justia.com/regulations/fedreg/2005/12/23/E5-7732.html
Document Number: E5-7728
https://regulations.justia.com/regulations/fedreg/2005/12/23/E5-7728.html
Document Number: E5-7635
This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license in the United States to practice the inventions described and claimed in Foreign Patent No. 0423277, JSC Docket No. MSC-21293-1-EP, ``Bio-Reactor Cell Culture Process'', Foreign Patent No. 1987294, JSC Docket No. MSC-21293-1-JP, ``Bio- Reactor Cell Culture Process'', International Application No. PCT/US98/ 06826, JSC Docket No. MSC-22859-1-EP, European Application No. 98915320.0 entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', International Application No. PCT/US98/ 06826, JSC Docket No. MSC-22859-1-JP, Japanese Application No. 10- 540983 entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', International Application No. PCT/US98/06826, JSC Docket No. MSC-22859-1-CA, Canadian Application No. 2286349 entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', International Application No. PCT/US98/06826, JSC Docket No. MSC-22859-1-IL, Israeli Application No. 132264 entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', International Application No. PCT/US98/06826, JSC Docket No. MSC-22859- 1-MX, Mexican Application No. 999265 entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', and International Application No. PCT/US98/06826, JSC Docket No. MSC-22859- 1-BR, Brazilian Application No. 98915320.0 entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'' to Renautus Bio Therapeutics, LLC, having its principal place of business in Baton Rouge, LA. The patent rights in the inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
https://regulations.justia.com/regulations/fedreg/2005/12/21/E5-7635.html
Document Number: 05-23994
https://regulations.justia.com/regulations/fedreg/2005/12/15/05-23994.html
Document Number: 05-23993
This is a final rule to amend the NASA FAR Supplement (NFS) to revise clause 1852.217-70 Property Administration and Reporting to change the name of ``NASA-Defense Purchase Request'' to ``NASA- Interagency Purchase Request'' and to replace the term ``Military Department'' to ``servicing agency'' in order to permit the use of this clause in interagency acquisitions with military departments and civilian agencies.
https://regulations.justia.com/regulations/fedreg/2005/12/15/05-23993.html
Document Number: E5-7170
https://regulations.justia.com/regulations/fedreg/2005/12/09/E5-7170.html
Document Number: E5-7169
https://regulations.justia.com/regulations/fedreg/2005/12/09/E5-7169.html
Document Number: E5-7167
https://regulations.justia.com/regulations/fedreg/2005/12/09/E5-7167.html
Document Number: E5-7166
https://regulations.justia.com/regulations/fedreg/2005/12/09/E5-7166.html
Document Number: E5-7164
https://regulations.justia.com/regulations/fedreg/2005/12/09/E5-7164.html
Document Number: E5-7163
https://regulations.justia.com/regulations/fedreg/2005/12/09/E5-7163.html
Document Number: E5-7162
https://regulations.justia.com/regulations/fedreg/2005/12/09/E5-7162.html
Document Number: E5-7161
https://regulations.justia.com/regulations/fedreg/2005/12/09/E5-7161.html
Document Number: E5-7160
https://regulations.justia.com/regulations/fedreg/2005/12/09/E5-7160.html
Document Number: E5-7008
https://regulations.justia.com/regulations/fedreg/2005/12/07/E5-7008.html
Document Number: E5-7007
https://regulations.justia.com/regulations/fedreg/2005/12/07/E5-7007.html
Document Number: E5-7006
https://regulations.justia.com/regulations/fedreg/2005/12/07/E5-7006.html
Document Number: E5-7005
https://regulations.justia.com/regulations/fedreg/2005/12/07/E5-7005.html
Document Number: E5-6900
NASA hereby gives notice that BCG Wireless of Washington, DC has applied for a partially exclusive license to practice the inventions described and claimed in U.S. Patent No. 5,983,162, entitled ``Computer Implemented Empirical Mode Decomposition Method, Apparatus and Article of Manufacture,'' and U.S. Patent No. 6,631,325, entitled ``Computer Implemented Empirical Mode Decom-position Method Apparatus, and Article of Manufacture Utilizing Curvature Extrema,'' and U.S. Patent No. 6,901,353, entitled ``Computing Instantaneous Frequency by Normalizing Hilbert Transform,'' which are assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. Written objections to the prospective grant of a license should be sent to NASA Goddard Space Flight Center. NASA has not yet made a determination to grant the requested license and may deny the requested license even if no objections are submitted within the comment period.
https://regulations.justia.com/regulations/fedreg/2005/12/06/E5-6900.html
Document Number: E5-6775
The Administrator of the National Aeronautics and Space Administration has determined that the establishment of the International Space Station Advisory Committee is necessary and in the public interest in connection with the performance of duties imposed upon NASA by law. This determination follows consultation with the Committee Management Secretariat, General Services Administration. Name of Committee: International Space Station Advisory Committee. Purpose and Objective: The Committee will advise the NASA Associate Administrator of the Space Operations Mission Directorate on matters related to the safety and operational readiness of the International Space Station. The Committee will draw on the expertise of its members and other sources to provide its advice and recommendations to the Agency. The Committee will hold meetings and make site visits as necessary to accomplish its responsibilities. The Committee will function solely as an advisory body and will comply fully with the provisions of the Federal Advisory Committee Act. Lack of Duplication of Resources: The Committee's functions cannot be performed by the agency, another existing committee, or other means such as a public meeting. Fairly Balanced Membership: Membership shall be comprised of experts in disciplines that permit the assessment of any aspect of the ISS program. Consultants or subject matter experts may be called in on a temporary basis to assist or augment the Committee when unique or additional expertise is required. The Associate Administrator of the Space Operations Mission Directorate shall ensure a balanced representation in terms of the points of view represented and the functions to be performed. Duration: Continuing. Responsible NASA Official: Mr. William Gerstenmaier, Associate Administrator, Space Operations Mission Directorate, National Aeronautics and Space Administration, 300 E Street, SW., Washington, DC 20546, telephone (202) 358-2015.
https://regulations.justia.com/regulations/fedreg/2005/12/02/E5-6775.html
Document Number: 05-22667
https://regulations.justia.com/regulations/fedreg/2005/11/16/05-22667.html
Document Number: 05-22666
https://regulations.justia.com/regulations/fedreg/2005/11/16/05-22666.html
Document Number: 05-22389
https://regulations.justia.com/regulations/fedreg/2005/11/10/05-22389.html
Document Number: 05-22065
https://regulations.justia.com/regulations/fedreg/2005/11/04/05-22065.html
Document Number: 05-21897
This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially exclusive license in the United States to practice the inventions described and claimed in U.S. Patent Nos. 5,153,131, entitled ``High Aspect Reactor Vessel and Method of Use''; 5,153,132, entitled ``Three-Dimensional Co-culture Process''; 5,153,133, entitled ``Method for Culturing Mammalian Cells in a Horizontally Rotated Bioreactor''; 5,155,034, entitled ``Three Dimensional Cell to Tissue Assembly Process''; 5,155,035, entitled `` Method for Culturing Mammalian Cells in a Perfused Bioreactor''; 5,308,764, entitled ``Multi-Cellular Three-Dimensional Living Mammalian Tissue''; 5,496,722, entitled ``Method for Producing Non-neoplastic, Three- dimensional, Mammalian Tissue and Cell Aggregates under Microgravity Culture Conditions and the Products Produced Therefrom''; 5,627,021, entitled ``Three- Dimensional Co-Culture Process''; 5,637,477, entitled ``Recombinant Protein Production and Insect Cell Culture and Process''; 5,846,807, entitled ``Media Compositions for Three-dimensional Mammalian Tissue Grown under Microgravity Culture Conditions''; 5,851,816, entitled ``Cultured High-Fidelity Three-Dimensional Human Urogenital Tract Carcinomas and Process''; 5,858,783, entitled ``Production of Normal Mammalian Organ Culture Using a Medium Containing MEM-alpha, Leibovitz L-15, Glucose Galactose Fructose''; 5,962,324, entitled ``Three Dimensional Optic Tissue Culture and Process''; 6,177,674, entitled ``Pathogen Propagation in Cultured Three-Dimensional Tissue Mass''; 6,485,963, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof'', 6,673,597, entitled ``Growth Stimulation of Biological Cells and Tissue by Electromagnetic Fields and Uses Thereof''; 6,730,498, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity''; 6,946,246, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', and U.S. Patent Application Serial Number 10/734,759, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', U.S. Patent Application Serial Number 10/947,786, entitled ``Production of Functional Proteins: Balance of Shear Stress and Gravity'', to Renautus Bio Therapeutics, LLC, having its principal place of business in Baton Rouge, LA. The patent rights in the inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
https://regulations.justia.com/regulations/fedreg/2005/11/03/05-21897.html
Document Number: 05-20846
This action withdraws the proposed rule published Friday, October 31, 2003 (68 FR 6204862049). NASA will issue internal guidance to automate the collection and transfer of Research and Development (R&D) abstracts to an appropriate central repository where they will be available for use by government agencies and other users.
https://regulations.justia.com/regulations/fedreg/2005/10/18/05-20846.html
Document Number: 05-20845
https://regulations.justia.com/regulations/fedreg/2005/10/18/05-20845.html
Document Number: 05-20561
https://regulations.justia.com/regulations/fedreg/2005/10/14/05-20561.html
Document Number: 05-19984
https://regulations.justia.com/regulations/fedreg/2005/10/05/05-19984.html
Document Number: 05-19983
This notice is issued in accordance with 35 U.S.C. 209(c)(1) and 37 CFR 404.7(a)(1)(i). NASA is contemplating the granting of an exclusive license in the United States to practice the inventions described and claimed in U.S. Patents 4,815,279, ``Hybrid Plume Plasma Rocket,'' 4,893,470, ``Method of Hybrid Plume Plasma Propulsion,'' and 6,334,302, ``Variable Specific Impulse Magnetoplasma Rocket Engine,'' to Ad Astra Technologies, Inc., having a place of business in Houston, TX and incorporated in the state of Delaware. The fields of use may be limited to exoatmospheric applications. The patent rights in the inventions have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
https://regulations.justia.com/regulations/fedreg/2005/10/05/05-19983.html